The Link Between Gum Disease and Heart Disease: What Australians Need to Know
📖 9 min read · Updated 08/04/2026
Quick Summary
✔ There is a well-established association between gum disease (periodontitis) and increased cardiovascular disease risk
✔ The American Heart Association and European Federation of Periodontology issued a joint consensus in 2013 confirming the evidence
❌ The relationship is an association — causation remains under active research
✔ Three proposed mechanisms: bacteraemia (bacteria entering the bloodstream), chronic systemic inflammation, and shared risk factors
✔ Treating gum disease reduces systemic markers of inflammation — including C-reactive protein (CRP)
❌ Good oral hygiene alone does NOT replace cardiac care — these conditions are managed in parallel, not instead of each other
✔ Gum disease affects approximately 50% of Australian adults — most of whom are also at cardiovascular risk age
Quick Answer
Research published in the Journal of Clinical Periodontology and endorsed by the American Heart Association (AHA) shows a consistent association between periodontitis (advanced gum disease) and increased risk of cardiovascular disease, including coronary artery disease and stroke. The proposed mechanisms include: bacteria from periodontal pockets entering the bloodstream and attaching to arterial plaques; chronic systemic inflammation driven by gum disease increasing vascular inflammation markers; and shared risk factors (smoking, diabetes, age). Clinical studies demonstrate that treating gum disease reduces systemic inflammatory markers including C-reactive protein (CRP). The LACALUT Australia clinical team recommends treating gum disease not only for oral health but as part of broader systemic health management.
What Is the Gum Disease–Heart Disease Connection?
The association between periodontitis and cardiovascular disease is one of the most studied topics in the oral-systemic health literature. Over 1,000 peer-reviewed studies have examined this relationship since the 1990s, and the weight of evidence is now substantial enough that the American Heart Association and the European Federation of Periodontology published a joint consensus statement in 2013 acknowledging the connection.
The Heart Foundation Australia also recognises that gum disease is associated with increased cardiovascular risk and recommends that Australians with heart conditions pay particular attention to their oral health.
This is NOT a fringe hypothesis. It is a well-documented and clinically recognised association — with active research continuing to clarify the precise causal mechanisms.
The Three Mechanisms Linking Gum Disease to Heart Disease
Research has identified three distinct biological pathways through which gum disease may influence cardiovascular health:
Mechanism 1: Bacteraemia — Oral Bacteria Entering the Bloodstream
The gum tissue in an active periodontitis patient is highly vascular and chronically inflamed. Every time a person with gum disease brushes their teeth, chews food, or receives dental treatment, bacteria from the gum pockets can enter the bloodstream — a condition called transient bacteraemia.
Several of the bacteria responsible for gum disease — including Porphyromonas gingivalis and Fusobacterium nucleatum — have been identified in arterial plaque samples from patients with coronary artery disease. Research published in the New England Journal of Medicine (2007) detected periodontal pathogens in atheromatous plaques, suggesting these bacteria may contribute to the inflammatory process that drives arterial plaque formation.
What this means practically
The bacteria responsible for destroying your gum tissue may also be travelling through your bloodstream to your arterial walls. This is NOT hypothetical — the same bacterial DNA has been found in both periodontal pockets and atherosclerotic plaques.
Mechanism 2: Chronic Systemic Inflammation
Gum disease is a chronic bacterial infection. Like any persistent infection, it triggers a sustained systemic inflammatory response from the immune system. This produces chronically elevated levels of inflammatory markers — particularly C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-α).
Elevated CRP is an established independent risk factor for cardiovascular disease. Research has consistently shown that patients with active periodontitis have higher systemic CRP levels than those with healthy gums — and that treating gum disease reduces CRP levels. A 2019 meta-analysis in the Journal of Clinical Periodontology found statistically significant reductions in CRP following non-surgical periodontal treatment.
These same inflammatory mediators drive arterial inflammation, plaque instability, and the clotting cascade that precipitates heart attacks and strokes. Chronic gum disease essentially keeps the body's inflammatory system on permanent low-level alert — with cardiovascular consequences.
Mechanism 3: Shared Risk Factors
Both gum disease and cardiovascular disease share several major risk factors — meaning that reducing risk for one may independently reduce risk for the other:
Your gum health directly affects your heart health.
LACALUT® Aktiv reduces the bacterial inflammation in the mouth that drives systemic cardiovascular risk.
Shop LACALUT AktivWhat the Clinical Evidence Shows About Treating Gum Disease and Cardiovascular Markers
Several high-quality clinical trials have examined whether treating gum disease improves cardiovascular risk markers. The results are consistently encouraging:
These studies do not prove that treating gum disease prevents heart attacks. They demonstrate that gum disease treatment reduces known cardiovascular risk markers — and that oral health is not a siloed concern separate from systemic health.
The Australian Context: Why This Matters for Australians Specifically
Cardiovascular disease remains Australia's leading cause of death, responsible for approximately 17,300 deaths in 2022 according to the Australian Bureau of Statistics. Simultaneously, the AIHW estimates that gum disease affects approximately half of all Australian adults.
The overlap between these two disease populations — particularly in the 45–75 age group — means hundreds of thousands of Australians are managing both conditions simultaneously, often without connecting the two.
The NHMRC National Oral Health Plan 2015–2024 explicitly identifies the oral-systemic connection as a priority area for Australian public health — specifically calling for integration of dental and medical care for patients with systemic conditions.
What This Means for Your Daily Oral Care Routine
The cardiovascular connection adds a compelling second reason — beyond tooth and gum preservation — to take gum disease seriously and treat it aggressively with clinical-grade products.
For more on the mechanisms and consequences of untreated gum disease, see: 7 Warning Signs of Gum Disease You Should Never Ignore and Can Gum Disease Be Reversed?
Oral health is cardiovascular health
LACALUT® Aktiv — 100 years of German clinical oral science. Reduces gum inflammation to protect both your mouth and your heart.
Shop Now — Free Shipping Over $99Medical disclaimer: This article provides general health information only. It does not constitute cardiac or dental medical advice. Consult your GP and dentist for personalised assessment.
